Patent Rights Wrangle Puts Law In Question

Courtesy of Neil Brake, Vanderbilt University  MARK III TANGO: Duke is dancing in court with former professor to control use of a free-electron laser like this one at Vanderbilt University. John M.J. Madey, long known as the father of the free-electron laser, has made his career in academic research, not business or law. So Madey did not craft the legal weapon that may close the patent law loophole allowing academic researchers to use patented technology without risking infringement suit

Written byPeg Brickley
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

John M.J. Madey, long known as the father of the free-electron laser, has made his career in academic research, not business or law. So Madey did not craft the legal weapon that may close the patent law loophole allowing academic researchers to use patented technology without risking infringement suits; it's a casualty of his attempt to assert rights over equipment he designed.

The scientist sued Duke University, alleging that the institution infringed his patents in connection with the Mark III free-electron laser (FEL). To defend the claim, Duke attempted to invoke the "experimental use" exception in patent law, which sometimes allows academic scientists to use new technologies without paying license fees. A federal appellate court took a dim view of the loophole and ruled in Madey's favor last year. Duke hopes the US Supreme Court will consider the case, and observers say that if Madey prevails in that court, this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies